Recruiting for Social Media Editor
Expert Review of Vaccines
About the role
The Expert Review of Vaccines is seeking a Social Media Editor to create and run an engaging new journal Twitter handle, to promote the journal, and further support its increasing reach and dissemination.
The successful candidate should be studying for or possess a doctoral degree in epidemiology, immunology and/or vaccine research. They should be able to work and communicate effectively with the journals’ Editorial team, as well as interact with the Taylor & Francis subject accounts, including @tandfmedicine.
The Social Media Editor will be expected to ‘tweet’ topical, popular, and newly published Expert Review of Vaccines content to the public, and to ‘tweet’ each newly published Expert Review of Vaccines article, and issue, once. Where appropriate, additional tweets should be made regarding the launch of articles collections, special focused issues, and updates to the Editorial Board. The successful candidate is likely to have proven experience of using social media channels in either their professional and/or personal lives.
The successful candidate will be appointed as ‘Social Media Editor’ on the journal’s Editorial Board, will be provided with guidance and data to support them in their role, and work with the Editors and Publisher to build awareness of Expert Review of Vaccines by connecting with the journal’s community online. They may also be invited to join journal meetings, either virtually, or in person (depending on location). The Social Media Editor will receive an honorarium of £700 (pro-rata where necessary), to cover journal-related expenses. As an Editorial Board member, they will also receive a 30% discount for Routledge and Taylor & Francis books.
About the journal
Expert Review of Vaccines (e-ISSN 1744-8395) is an Open Access, MEDLINE-indexed, international journal publishing rigorously peer-reviewed research in the development, application, and clinical effectiveness of new vaccines.
The vaccine field has been transformed by recent technological advances, but there remain many challenges in the delivery of cost-effective, safe vaccines. Expert Review of Vaccines facilitates decision making to drive forward this exciting field.
The journal features cutting edge reviews and original articles on vaccines, the immune response, and the powerful impact of immunization against infectious diseases. We also cover vaccine technologies and platforms, adjuvants, therapeutic vaccines, and vaccination for the control of non-communicable diseases.
Alongside review articles, the journal welcomes clinically relevant and novel original research. Pharmacoeconomic studies are considered if there is clear clinical relevance.
Expert Review of Vaccines already successfully serves a huge readership, with over 528,000 downloads in 2022.
To apply, please submit via email the following to Liam Hobbins (Portfolio Manager) via [email protected]:
- brief CV: one-page maximum
- cover letter: outlining how you meet the attributes listed above, your vision for the account, and how you would build awareness and maximise dissemination of journal content
- three sample social media ‘posts’: suitable for three different social media platforms (e.g. Twitter, Facebook, LinkedIn and/or Instagram)
- the posts should include all text and media related to the post, and pay due regard to the conventions, character and/or word limits relevant to the platform, and include any necessary or desired links, or ‘tags’
- timing of the post may also be taken into consideration
- the three different posts should all be promoting the following article:
Success of nano-vaccines against COVID-19: a transformation in nanomedicine
These can be mocked up, and sent through as a separate document; continuing on from the CV; alternatively, you may find it easier to actually post from any existing social media accounts you have, and send through direct links to, or screenshots of, the posts.
The journal is committed to ensuring diversity, equity and inclusion within its editorial team and decision making processes. All applications will be treated as strictly confidential, and each will be judged on its merits without bias for seniority of institutional affiliation. We do not discriminate on the basis of race, color, ancestry, national origin, religion, or religious creed, mental or physical disability, medical condition, genetic information, sex (including pregnancy, childbirth, and related medical conditions), sexual orientation, gender identity, gender expression, age, marital status, military or protected veteran status, citizenship, or other protected characteristics.